Positive ANA aids in the exclusion of disorders with comparable clinical symptoms to SLE, such as hemolytic uremic syndrome (27); however, obligatory positive ANA may reduce the sensitivity of EULAR/ACR 2019, especially in childhood-onset SLE. The gene discussed is BTG3; the disease is hemolytic-uremic syndrome.